| Name | D-Ribofuranose |
|---|---|
| Synonyms |
(3R,4S,5R)-5-(Hydroxymethyl)tetrahydro-2,3,4-furantriol
MFCD00005363 D-Ribose Ribofuranose Ribose MFCD00167010 D-(-)-Ribose EINECS 200-059-4 D-(−)-Ribose D-Ribofuranose |
| Description | D-Ribofuranose (D-Ribose) is an endogenous metabolite present in Cerebrospinal_Fluid that can be used for the research of Ribose 5 Phosphate Isomerase Deficiency and Medium Chain Acyl Co A Dehydrogenase Deficiency[1][2]. |
|---|---|
| Related Catalog | |
| Target |
Microbial Metabolite |
| In Vitro | Endogenous metabolites is defined as those that are annotated by Kyoto Encyclopedia of Genes and Genomes as substrates or products of the ~1900 metabolic enzymes encoded in our genome. It is clear in the body of literature that there are documented toxic properties for many of these metabolites[1]. |
| References |
| Density | 1.7±0.1 g/cm3 |
|---|---|
| Boiling Point | 375.4±42.0 °C at 760 mmHg |
| Molecular Formula | C5H10O5 |
| Molecular Weight | 150.130 |
| Flash Point | 180.8±27.9 °C |
| Exact Mass | 150.052826 |
| LogP | -1.47 |
| Vapour Pressure | 0.0±1.9 mmHg at 25°C |
| Index of Refraction | 1.612 |